Delivery Order SPE2DB20D1100-SPE2DB23FD4C1

Award Date 9/1/23
Potential Completion Date 9/5/23
Potential Value $18
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fourteen thousand six dollars and six cents ($114,006) to Amerisourcebergen Drug Corporation for the supply of one hundred (100) phentermine hydrochloride 37.5 mg tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one (1) day, from June 29, 2023 through June 30, 2023. No set aside designation or subcontracting...
The Defense Logistics Agency awarded a $36,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 units of 37.5 mg phentermine hydrochloride tablets. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the DLA's pharmaceutical supply needs. No set aside designation or subcontractors were identified. The one-day period of...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order valued at seventeen thousand seven hundred dollars to Amerisourcebergen Drug Corporation for one hundred tablets of phentermine hydrochloride 37.5 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning August 21, 2023 through August 22, 2023. No set aside designation or subcontracting details were...
The Defense Logistics Agency awarded a $54,780 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 phentermine hydrochloride 37.5 mg tablets. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all items to be delivered by July 21, 2023. As the DLA manages the global supply...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-nine thousand one hundred fourteen dollars to Amerisourcebergen Drug Corporation for the supply of one hundred tablets of phentermine hydrochloride 37.5 mg. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from August 9th through August 10th, 2023. The Defense Logistics Agency is a combat support agency under the Department of...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventeen thousand seven hundred dollars to Amerisourcebergen Drug Corporation for the procurement of one hundred tablets of phentermine hydrochloride 37.5 mg. The place of performance is the contractor's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from July 19, 2023 through July 20, 2023. No set aside designation or subcontractors were identified. The Defense Logistics...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately sixteen thousand three hundred dollars to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation. The delivery order is for one hundred tablets of phentermine hydrochloride 37.5 mg to be delivered to a facility in Conshohocken, Pennsylvania by July 18, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this...
The Defense Logistics Agency Troop Support Medical awarded a $177,160 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of phentermine hydrochloride 37.5 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 3, 2023 through August 4, 2023. No major subcontractors or set aside designations were identified. This delivery order was issued against an existing...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at eleven thousand eight hundred twenty dollars to Amerisourcebergen Drug Corporation for the supply of one hundred tablets of phentermine hydrochloride 37.5 mg. The place of performance is the contractor's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from June 23, 2023 through June 26, 2023 to fulfill the Defense Logistics Agency's requirements for this...
The Defense Logistics Agency awarded a $29,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 tablets of phentermine hydrochloride 37.5 mg. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by August 22, 2023 to support the DLA's medical supply needs. No subcontractors or set aside designations were identified. The DLA manages the global supply chain for the United States military and this order for a common...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FD4C1
    Delivery Order

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,700 to Amerisourcebergen Drug Corporation for 100 tablets of phentermine hydrochloride 37.5 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from September 1, 2023 through September 5, 2023. As the DLA is responsible for supplying the United States military worldwide, this delivery order was likely issued to fulfill pharmaceutical needs for one of the agency's treatment programs. No major subcontractors or set aside designations were indicated.

Generated 12/21/23, 11:45 PM